Search

everythinglearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Weight-loss drugs are not linked to suicidal thoughts.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Semaglutide helps obese PCOS patients lose weight and improve health.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

GLP-1 agonists may increase the risk of hair loss.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Semaglutide does not significantly increase the risk of hair loss.

Valette® is an effective birth control pill that also reduces greasy hair and skin.

Semaglutide may worsen eating disorders in vulnerable individuals.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

Finasteride and bicalutamide can affect blood sugar, so diabetics need monitoring.

Finasteride and bicalutamide can affect blood sugar, so diabetics need monitoring.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.